Outcomes after autologous stem cell transplantation in relapsed or refractory Hodgkin disease: The Duke experience

被引：0
|
作者：
Kim, D. W. [1 ]
Misra, D. [1 ]
Clough, R. W. [1 ]
Long, G. D. [1 ]
Prosnitz, R. G. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8100
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
    Sureda, Anna
    Andre, Marc
    Borchmann, Peter
    da Silva, Maria G.
    Gisselbrecht, Christian
    Vassilakopoulos, Theodoros P.
    Zinzani, Pier Luigi
    Walewski, Jan
    BMC CANCER, 2020, 20 (01)
  • [42] Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma
    Merryman, Reid W.
    Redd, Robert A.
    Nishihori, Taiga
    Chavez, Julio
    Nieto, Yago
    Darrah, Justin M.
    Rao, Uttam
    Byrne, Michael T.
    Bond, David A.
    Maddocks, Kami J.
    Spinner, Michael A.
    Advani, Ranjana H.
    Ballard, Hatcher J.
    Svoboda, Jakub
    Singh, Anurag K.
    McGuirk, Joseph P.
    Modi, Dipenkumar
    Ramchandren, Radhakrishnan
    Romancik, Jason
    Cohen, Jonathon B.
    Frigault, Matthew J.
    Chen, Yi-Bin
    Serritella, Anthony, V
    Kline, Justine
    Ansell, Stephen
    Nathan, Sunita
    Rahimian, Maryam
    Joyce, Robin M.
    Shah, Mansi
    David, Kevin A.
    Park, Steven
    Beaven, Anne W.
    Habib, Alma
    Bachanova, Veronika
    Nakhoda, Shazia
    Khan, Nadia
    Lynch, Ryan C.
    Smith, Stephen D.
    Ho, Vincent T.
    LaCasce, Ann
    Armand, Philippe
    Herrera, Alex F.
    BLOOD ADVANCES, 2021, 5 (06) : 1648 - 1659
  • [43] Autologous hematopoietic stem cell transplantation in children with relapse or refractory Hodgkin disease
    de Castro, Claudio Galvo, Jr.
    Gregianin, Lauro Jose
    Brunetto, Algemir Lunardi
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2006, 28 (11) : 772 - 772
  • [44] Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma
    Broeckelmann, P. J.
    Mueller, H.
    Casasnovas, O.
    Hutchings, M.
    von Tresckow, B.
    Jurgens, M.
    McCall, S. J.
    Morschhauser, F.
    Fuchs, M.
    Borchmann, P.
    Moskowitz, C. H.
    Engert, A.
    ANNALS OF ONCOLOGY, 2017, 28 (06) : 1352 - 1358
  • [45] Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma
    Herrera, A. F.
    Palmer, J.
    Martin, P.
    Armenian, S.
    Tsai, N-C
    Kennedy, N.
    Sahebi, F.
    Cao, T.
    Budde, L. E.
    Mei, M.
    Siddiqi, T.
    Popplewell, L.
    Rosen, S. T.
    Kwak, L. W.
    Nademanee, A.
    Forman, S. J.
    Chen, R.
    ANNALS OF ONCOLOGY, 2018, 29 (03) : 724 - 730
  • [46] Autologous stem cell transplantation for relapsed/refractory Hodgkin's disease using Cyclophosphamide, Etoposide, BCNU and ± Platinum.
    Lerner, D
    Tavares, RB
    De Lima, MG
    Bouzas, LF
    Da Matta, JR
    Melo, T
    Byington, R
    Tabak, D
    BLOOD, 1999, 94 (10) : 402B - 402B
  • [47] Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) after Treatment with Nivolumab for Relapsed/Refractory Hodgkin Lymphoma
    Armand, Philippe
    Zinzani, Pier Luigi
    Collins, Graham P.
    Cohen, Jonathon B.
    Halwani, Ahmad S.
    Carlo-Stella, Carmelo
    Millenson, Michael M.
    Provencio, Mariano
    Domenech, Eva Domingo
    Roth, Lisa Giulino
    Castagna, Luca
    Kato, Kazunobu
    McKiver, Mihaela Popa
    Sumbul, Anne
    Zhu, Lili
    Santoro, Armando
    BLOOD, 2016, 128 (22)
  • [48] Dose intensification with autologous stem cell transplantation in relapsed and resistant Hodgkin's disease
    Anselmo, AP
    Cavalieri, E
    Meloni, G
    Alimena, G
    Cantonetti, M
    Enrici, RM
    Tosti, ME
    Osti, MF
    Gianfelici, V
    Mandelli, F
    HAEMATOLOGICA, 2002, 87 (05) : 507 - 511
  • [49] Ifosfamide salvage treatment before autologous stem cell transplantation in patients with refractory and relapsed Hodgkin's lymphoma:: a GELA experience
    Gisselbrecht, C
    Mounier, N
    Fermé, C
    Brice, P
    ANNALS OF ONCOLOGY, 2003, 14 : 39 - 41
  • [50] Treatment outcomes and patterns of failure following autologous stem cell transplant for relapsed/refractory Hodgkin's disease.
    Mohideen, N
    Khan, U
    Parthasarathy, M
    Toor, A
    Rodriguez, T
    Klein, J
    Stiff, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 602S - 602S
12345